THE LEVELS OF FOLIC ACID AND HOMOCYSTEINE IN THE BLOOD OF WOMEN WITH POLYCYSTIC OVARY SYNDROME AND THE DYNAMICS OF THESE INDICATORS DURING OF FOLATE THERAPY

Authors

  • Arkhypkina T. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Karachentsev Yu. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Bondarenko V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Lyubimovа L. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2016.2.01

Keywords:

polycystic ovary syndrome, folic acid, homocysteine, folate treatment

Abstract

It were examined 70 young women with PCOS. It was established, that these patients have lower levels of folic acid than healthy women, 47 % — reduction below reference values of norms, 52.8 % — hyperhomocysteinemia. Folic acid treatment at a dose of 5 mg/day helped to normalize its levels for 12 week therapy at that at women with normal body weight normalization was faster. The concentration of homocysteine during treatment as high as indicators of healthy women at patients with normal weight for 12 weeks of therapy, and at patients with obesity — for 24 weeks. Determination in blood levels of folate and homocysteine should be included a comprehensive examination of this category of patients, particularly at the stage pregravid period.

References

Bodawy A, Elnashar A. Int J Womens Health 2011;3:25-35.

Trikudanathan S. Med Clin North AM 2015;99(1):221-235.

Marshall JC, Dunaif A. Fertil Steril 2012; 97(1):18-22.

Caserta D, Adducchio G, Picchia S, et al. Gynecol Endocrinol 2014; 30(6):397-402.

Bodawy A, State O, Gawad SS, et al. Gynecology 2007; 131(1):68-72.

Maleedhu P, Vijayabhaskar M, Sharma SSB, et al. J Clin Diagnostic Res 2014; 89(2):31-33.

Gerhard GT, Duell PB. Curr Opin Lipido 1999;10(15):417-428.

Pentjuk OO, Lucjuk MB, Andrushko II, Postovitrenko KP. Ukr Biohim Zhurn 2003; 75(1):5-16.

Vanaerts LA, Blom HJ, Deabreu RA, et al. Teratology 1994; 50(5):348-360.

Kerkeshko GO, Arutjunjan AV, Arzhanova ON,Miljutina JuP. Zhurn Akusherstva I Zhenskih Boleznej 2013; 62(6):25-36.

Grodnickaja EJe. Ros Vestn Akushera Ginekologa 2010; 4:20-24.

Pietrzik K, Bailey L, Shane B. Clin Pharmacokinet 2010; 49(8):535-548.

Simpson JL, Bailey LB, Pietrzik K, et al. J Matern Fetal Neonatal Med 2010; 23(12):1323-1343.

Crider KS, Yang TP, Berry RJ, et al. Adv Nutr 2012; 3(1):21-38.

Grodnickaja EJe, Kurcer MA, Shamanova MB. Problemy Reprodukcii 2008; 14(6):84-86.

Forges T, Pellanda H, Divigent C, et al. Gynecol Obstet 2008; 36(9):936-939.

Malysheva LI, Fetisova IN, Fetisov NS, Gordiva AV. Med Forum 2015; 2(1):52-56.

Monnier-Barbarino P, Alberto JM, Guéant-Rodriguez RM, et al. Hum Reprod 2007; 13(3):225-238.

Dubey P, Gupta N, Dwivedi S. Inter J Reprod Contracept Obstet Gynecol 2013; 2(2):165-171.

Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Am J Clin Nutr 2006; 84(1):156-161.

Pustotina OA, Ahmedova AJe. Jeffektivnaja Farmakoterapija 2014; 35(3):66-74.

Kim MW, Hong SC, Choi JS, et al. Jeffektivnaja Farmakoterapija 2014; 23(2):24-30.

Makacarija AD, Beloborodova EV, Bajmuradova SM, Bicadze VO. Gipergomocisteinemija i oslozhnenija beremennosti, Moskva, 2005: 41 p.

Homocysteine Lowering Trialists’ Collaboration. Am J Clin Nutr 2005; 82(4):806-812.

Tapil’skaja NI, Ajdukov SN. Ginekologija 2013;15(3):70-74.

Dobrohotova JuJe, Dzhobava JeM, Hejdar LH, et al.Problemy Reprodukcii 2006; 12(1):98-101.

Wolters M, Strohle A, Hahn A. Z Gerontol Geriatr 2004; 37(2):109-135.

Zhukova VB, Protas JuI, Gnidenko KJu, Zelena II. Suchasna Gastroenterologija 2006; 1:87-92.

Gromova OA. Farmakoterapija 2013; 5:44-49.

Moat SJ, Lang D, McDowell IF, et al. J Nutr Biochem 2004; 15(2):64-79.

Verhaar ML, Stroes E, Rabelink IJ. Arteriosclerosis Thrombosis Vascular Biology 2002; 22:6-13.

The Rotterdam ESHRE/ ASRM- sponsored PCOS consensus workshop group. Hum Reprod 2004;19(1):41-47.

Yilmaz M, Biri A, Bukan N, et al. Gynecol Endocrinol 2005; 20(5):258- 263.

Stroev EA, Makarova VG. Praktikum po biologicheskoj himii: uchebnoe posobie, Moskva, 1986: 174 p.

Yilmaz VT, Coban E, Avci AB, et al. Turk Neph Dial Transpl 2014; 23(2):91-94.

Caruso R, Campolo J, Sedda V, et al. J Cardiovasc Pharmacol 2006; 47(4):549-555.

Tsanadis G, Vartholomatos G, Korkontzelos I, et al. Hum Reprod 2002; 17(2):314-319.

Downloads

Published

2016-06-08

How to Cite

Arkhypkina, T., Karachentsev, Y., Bondarenko, V., & Lyubimovа L. (2016). THE LEVELS OF FOLIC ACID AND HOMOCYSTEINE IN THE BLOOD OF WOMEN WITH POLYCYSTIC OVARY SYNDROME AND THE DYNAMICS OF THESE INDICATORS DURING OF FOLATE THERAPY. Problems of Endocrine Pathology, 56(2), 7-16. https://doi.org/10.21856/j-PEP.2016.2.01

Issue

Section

CLINICAL ENDOCRINOLOGY